China Surgical Skin Disinfection Supplier – Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) – Lircon
Short Description:
China Surgical Skin Disinfection Supplier – Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) – Lircon Detail:
Major ingredient and concentration
Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) is a disinfectant with Ethacridine Lactate and Dodecyl Dimethyl Benzyl Ammonium Chloride as the main active ingredients. The Ethacridine Lactate content is 0.22g/L-0.022g/L(W/V), and the Dodecyl Dimethyl Benzyl Ammonium Chloride content is 0.42g/L-0.042g/L(W/V).
Germicidal spectrum
Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) can kill the microorganisms such as enteric pathogenic bacteria, pyogenic coccus, pathogenic yeast and hospital infection common germs.
Features and Benefits
1. For rinsing, cleaning and sterilizing the entire skin surface.
List of Uses
| Animal care facilities | Military bases |
| Community health centers | Operating rooms |
| Donning rooms | Orthodonist offices |
| Emergency medical settings | Outpatient surgical centers |
| Hospitals | Schools |
| Laboratories | Surgical centers |
Product detail pictures:
Related Product Guide:
We strive for excellence, services the customers", hopes to be the top cooperation team and dominator business for personnel, suppliers and prospects, realizes benefit share and continual promotion for China Surgical Skin Disinfection Supplier – Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) – Lircon, The product will supply to all over the world, such as: Bangalore, Manila, Burundi, Our company regards "reasonable prices, high quality,efficient production time and good after-sales service" as our tenet. We hope to cooperate with more customers for mutual development and benefits in future. Welcome to contact us.
By Erin from Johor - 2017.08.28 16:02
We are long-term partners, there is no disappointment every time, we hope to maintain this friendship later!
By ROGER Rivkin from Turin - 2017.11.01 17:04
